8-K: InTest Q4 2025 Revenue Beats, Diversification Fuels Growth

InTest Corporation reported Q4 2025 EPS of $0.10 on revenue of $32.8 million, exceeding guidance and showing strong momentum from non-semiconductor markets.

Summary

• InTest Corporation announced financial results for the fourth quarter and full year ended December 31, 2025.
• Fourth quarter 2025 revenue was $32.8 million, a 25.1% increase sequentially from Q3 2025, and exceeded the company's guidance range.
• Q4 2025 diluted earnings per share (EPS) was $0.10, a significant improvement from a net loss of $(0.08) per diluted share in Q3 2025.
• Gross margin expanded by 350 basis points sequentially to 45.4% in Q4 2025, driven by manufacturing efficiency initiatives and new product sales.
• Orders remained strong at $37.5 million in Q4 2025, primarily driven by Auto/EV and Life Sciences sectors.
• Year-end backlog reached $53.9 million, an increase of 9.4% sequentially and 36% from December 31, 2024.
• Nearly 80% of Q4 2025 revenue was derived from non-semiconductor end markets, reflecting successful diversification efforts.
• For the full year 2025, revenue was $113.8 million, a 12.9% decrease from $130.7 million in 2024.
• Full year 2025 resulted in a net loss of $(2.5) million, or $(0.21) per diluted share, compared to net earnings of $2.9 million, or $0.24 per diluted share, in 2024.
• The company reduced total debt by $7.6 million during 2025 and generated $7.3 million cash from operations.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to the strong sequential rebound in Q4 2025, exceeding revenue guidance, significant gross margin expansion, and successful market diversification efforts, despite a challenging full year 2025. The positive outlook for 2026 further supports a favorable sentiment.

Positives

• Q4 2025 revenue of $32.8 million exceeded the company's guidance range and increased 25.1% sequentially from Q3 2025.
• Q4 2025 diluted EPS of $0.10 represents a strong rebound from a net loss in the prior quarter.
• Gross margin expanded significantly to 45.4% in Q4 2025, a 350 basis point sequential increase, attributed to manufacturing efficiencies and new product contributions.
• Orders remained strong at $37.5 million in Q4 2025, driven by continued strength in Auto/EV and Life Sciences, and increased 22.2% year-over-year.
• Year-end backlog grew to a healthy $53.9 million, up 9.4% sequentially and 36.4% from December 31, 2024, with approximately 60% expected to ship beyond Q1 2026.
• Nearly 80% of Q4 2025 revenue came from non-semiconductor end markets, demonstrating successful market diversification.
• The market diversification strategy has delivered approximately 20% compound average growth rate over the last five years.
• Total debt was reduced by $7.6 million during 2025, and $1.4 million in Q4 2025, strengthening the balance sheet.
• Generated $7.3 million in cash from operations for the full year 2025.

Negatives

• Full year 2025 revenue declined by $16.9 million, or 12.9%, to $113.8 million compared to $130.7 million in 2024.
• Full year 2025 resulted in a net loss of $(2.5) million, or $(0.21) per diluted share, a significant decrease from net earnings in 2024.
• Q4 2025 revenue declined by $3.8 million, or 10.3%, compared to the prior-year period (Q4 2024).
• The semiconductor (Semi) business continued to experience sluggishness, with Q4 2025 Semi revenue down 43.1% year-over-year and 29.5% sequentially.
• Operating income for Q4 2025 decreased by 38.6% year-over-year to $1.3 million.
• Cash, cash equivalents and restricted cash decreased by $3.0 million sequentially in Q4 2025 and by $1.772 million for the full year 2025.

Risks

• Ability to execute on the VISION 2030 Strategy.
• Ability to realize potential benefits of acquisitions and successfully integrate acquired operations.
• Ability to grow the company's presence in key target and international markets.
• Challenges in managing supply chain disruptions.
• Ability to convert backlog to sales and ship products in a timely manner.
• The success of the company's strategy to diversify its markets.
• Impact of inflation on the company's business and financial condition.
• Indications of a change in the market cycles in the semiconductor market or other markets served.
• Changes in business conditions and general economic conditions both domestically and globally, including changes in U.S. and/or foreign trade policy, rising interest rates, and fluctuations in foreign currency exchange rates.
• Changes in the demand for semiconductors.
• Access to capital and the ability to borrow funds or raise capital to finance potential acquisitions or for working capital.
• Changes in the rates and timing of capital expenditures by the company's customers.

Future Outlook

InTest projects year-over-year growth for 2026, supported by a healthy backlog, recovering customer capital spending trends, and contributions from its growing portfolio of engineered solutions. For Q1 2026, the company anticipates revenue between $31 million and $33 million, with a gross margin of approximately 44%, and operating expenses of $13.3 million to $13.7 million. For the full year 2026, InTest expects revenue between $125 million and $130 million, a gross margin of approximately 45%, and operating expenses of $53 million to $55 million. A modest pick-up in demand from semiconductor customers is anticipated in the second half of 2026.

Management Comments

• "Orders remained strong at $37.5 million for the fourth quarter as Auto/EV customers moved forward with new model year programs coupled with the success we are seeing with the diversification in Life Sciences. We continue to see improved customer spending sentiment across our increasingly diversified markets." Nick Grant, President and CEO.
• "As a result, our 2025 year-end backlog was a healthy $53.9 million, an increase of 36% from December 31, 2024." Nick Grant, President and CEO.
• "Revenue exceeded our guidance range and rebounded in the fourth quarter, reflecting the gradual recovery in customer capital spending we saw taking shape in the middle of the year, particularly in the Industrial and Defense/Aerospace end markets. We also benefited from the continued growing acceptance of new products and approximately $2 million in shipments which slipped out of the third quarter." Nick Grant, President and CEO.
• "Gross margin reached 45.4%, driven by manufacturing efficiency initiatives undertaken over the course of 2025 and a lift from sales of new products at Alfamation and Acculogic. Notably, we achieved this quarters gross margin level despite the sluggishness of our historically significant Semi business." Nick Grant, President and CEO.
• "For 2026, we project year-over-year growth supported by a healthy backlog, recovering customer capital spending trends, and contributions from our growing portfolio of highly valued engineered solutions. From discussions with customers, we anticipate a modest pick-up in demand from Semi customers in the second half of the year. Combined with a leaner cost structure, we believe InTest is well-positioned to sustain profitability throughout the year as we continue to execute our VISION 2030 Strategy of increased diversification as we scale the business." Nick Grant, President and CEO.

Industry Context

StockSavvy.ai notes that InTest Corporation's Q4 2025 results highlight a successful pivot away from the historically cyclical semiconductor market, with nearly 80% of revenue now derived from diversified end markets like Auto/EV, Life Sciences, Industrial, and Defense/Aerospace. This strategy has enabled the company to achieve strong sequential growth and margin expansion despite continued weakness in the semiconductor sector, a trend that many specialized equipment providers are navigating by seeking broader market exposure. The anticipated modest recovery in the semiconductor market in H2 2026 could provide an additional tailwind, complementing the established growth in diversified segments.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Potential for increased shareholder value due to strong Q4 performance, positive 2026 outlook, and successful diversification strategy, despite a challenging full year 2025.
• Employees: Continued focus on manufacturing efficiency initiatives and a leaner cost structure may impact operational roles, while growth in diversified markets could create new opportunities.
• Customers: Benefit from continued innovation and a growing portfolio of highly valued engineered solutions, particularly in Auto/EV and Life Sciences.
• Creditors: Strengthened balance sheet through significant debt reduction ($7.6 million in 2025) and generation of cash from operations ($7.3 million in 2025) improves creditworthiness.

Next Steps

• Host a conference call and webcast on February 27, 2026, at 8:30 a.m. ET to review results and discuss strategy and outlook.
• Continue executing the VISION 2030 Strategy focused on innovation, customer diversity, and global presence.
• Anticipate a modest pick-up in demand from semiconductor customers in the second half of 2026.
• Focus on sustaining profitability throughout 2026 with a leaner cost structure.

Key Dates

Recommendation

While InTest Corporation experienced a challenging full year 2025 with a net loss, the Q4 2025 results demonstrate a significant sequential rebound, exceeding revenue guidance and showing strong gross margin expansion. The company's successful diversification strategy, with nearly 80% of Q4 revenue from non-semiconductor markets, and a healthy backlog provide a solid foundation for future growth. The positive outlook for 2026, including projected year-over-year revenue growth and anticipated semiconductor market recovery in H2, suggests a positive trajectory. For existing investors, holding the stock allows them to benefit from this turnaround and strategic execution. For new investors, it presents a potential entry point for a company demonstrating resilience and strategic foresight, but the full-year decline warrants a 'hold' rather than a 'buy' until sustained profitability is clearly demonstrated.

Keywords

InTest Corporation, INTT, Q4 2025 Earnings, Financial Results, Semiconductor, Auto/EV, Life Sciences, Defense/Aerospace, Industrial, Test Technology, Process Technology, Market Diversification, Backlog, Gross Margin, EPS, Debt Reduction, Vision 2030 Strategy